Research by Yvonne Janssen-Heininger, Ph.D., and Reem Aboushousha, Ph.D, uncovered a novel facet of glutaredoxin, a prominent player in humans’ antioxidant defense system . The findings bear substantial implications in the field of cancer biology.

Each summer, many rising second-year medical students engage in clinical, basic science or health policy-related research projects under the guidance of expert faculty. The students choose their topics based on personal passions and immerse themselves in projects tackling medical puzzles and unmet health needs. Engaging in research can be among the most valuable experiences during a medical education.

Kristin Flanary, known internationally as her social media alter ego, Lady Glaucomflecken, is on a mission to make health care a little more human. Through storytelling, her keynote address on September 29 at the Women’s Health and Cancer Conference will highlight her perspective as a caregiver and “co-survivor” of her husband’s two cancer occurrences and sudden cardiac arrest.

(AUGUST 3, 2023) At the 2023 International Mesothelioma Interest Group (iMig) conference in June, Brian Cunniff, Ph.D., assistant professor of pathology, presented early experience with “an exciting new therapeutic option for patients suffering with mesothelioma” to a global audience of clinicians, scientists, and allied professionals, according to Business Wire.

Thanks to positive results from a new clinical trial in which the UVM Cancer Center and Chris Holmes, M.D., Ph.D., professor of medicine, played a role, the five to 25 percent of cancer patients who develop venous thrombosis will no longer need to inject themselves with a blood thinner.

This summer, 20 summer scholars were awarded $4,000 stipends to deepen their engagement, hone their skills, and drive towards new discoveries under the guidance of a UVM Cancer Center mentor. Among the group is Kanayo Ikeh, this year’s 2023 Juckett Summer Student Scholar.

Former New England Patriot and three-time Super Bowl champion Joe Andruzzi visited the UVM Cancer Center’s patients and care teams on June 22, 2023 as part of a road trip celebrating his namesake Joe Andruzzi Foundation’s 15th anniversary.

This summer, the UVM Cancer Center and the Vermont Lake Monsters are raising awareness about skin cancer prevention.

UVM Cancer Center member David J. Seward, M.D., Ph.D., assistant professor of pathology and laboratory medicine, received a prestigious two-year National Cancer Institute R21 grant to investigate why lung cancers with a certain set of mutations demonstrate immunotherapy resistance.

(MARCH 30, 2023) Researchers at the UVM Cancer Center released the findings of a study showing fewer women being screened for breast cancer, NBC5 reported. The study reports that Vermont had the second-largest drop in the entire country in screenings for women over the age of 40 between 2009 and 2018.

UVM Cancer Center researchers Sarah Nowak, Ph.D., and Brian Sprague, Ph.D., found that a 2009 U.S. Preventive Services Task Force change in guidelines led to an unintended consequence: a decline in mammography screening rates for all age groups, including the 50-74 group, which is most at risk of developing breast cancer and most in need of screenings. Their results were recently published in The American Journal of Preventative Medicine.

Alan Howe, Ph.D., professor of pharmacology, has been appointed to serve as associate director of cancer research, training and education coordination for the University of Vermont Cancer Center (UVMCC) .